SCHEMBL7974069

SCHEMBL7974069

O=c1[nH]c(-c2ccccc2)nc2ncn(Cc3cccc(C(F)(F)F)c3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.46
MAPT P10636 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
CXCR2 P25025 1/20 0.43
ROCK2 O75116 1/20 0.42
ROCK1 Q13464 1/20 0.42
GRIN1 Q05586 1/20 0.41
GRIN2B Q13224 1/20 0.41
MEN1 O00255 1/20 0.41
TNF P01375 1/20 0.41
POLB P06746 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984971 0.94 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2KMT2AHPGDCXCR2
SCHEMBL7987948 0.89 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2KMT2AHPGDCXCR2
SCHEMBL7985787 0.86 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2KMT2AHPGDMKNK1
SCHEMBL7975265 0.86 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2KMT2AHPGDRXFP1
SCHEMBL7988015 0.84 HPGD (0.43) ALDH1A1SMN1; SMN2KMT2AHPGDMAPT
SCHEMBL7988662 0.84 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGDMKNK1
SCHEMBL7974266 0.84 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2KMT2AHPGDMAPT
SCHEMBL7974074 0.84 CXCR2 (0.45) MAPTLMNATP53RXFP1MKNK1
SCHEMBL7987251 0.82 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2KMT2AHPGD
SCHEMBL7974016 0.82 GAA (0.56) ALDH1A1SMN1; SMN2KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed